Comparison of Pediatric Demyelinating Diseases using Axonal and Myelin-Sensitive MRI

Fang Frank Yu1, Elayne Joe2, Niloufar Saadat2

  • 1From the Department of Radiology (F.F.Y., N.S., P.S., K.R.), Advanced Imaging Research Center (F.F.Y., J.R.), Neurology (P.S., B.G.), UT Southwestern Medical Center, Dallas, TX, United States and UT Southwestern School of Medicine (E.J.), Dallas, TX, United States. FrankF.Yu@UTSouthwestern.edu.

Abstract

Insights

Advanced MRI biomarkers reveal distinct microstructural changes in pediatric demyelinating diseases. Multiple sclerosis (MS) shows greater myelin loss compared to MOGAD and NMOSD, aiding in diagnosis and treatment.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarkers

Background:

  • Pediatric demyelinating diseases cause significant neurological disability.
  • Conventional MRI lacks specificity in differentiating white matter pathologies.
  • Advanced MRI techniques offer potential for improved characterization.

Purpose of the Study:

  • To utilize advanced MRI biomarkers, macromolecular tissue volume (MTV) and neurite orientation dispersion and density imaging (NODDI), to assess myelin integrity (MVF), axonal density (NDI), and g-ratio.
  • To differentiate microstructural alterations in pediatric multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).

Main Methods:

  • Cross-sectional study of 39 pediatric patients (MS, NMOSD, MOGAD) and 7 healthy controls using 3 Tesla MRI.
  • Acquisition of multi-echo gradient echo and multi-shell diffusion sequences to compute MTV and NODDI metrics.
  • Segmentation of lesional and normal-appearing white matter (NAWM) for comparison of imaging metrics (MVF, NDI, g-ratio) and correlation with clinical data.

Main Results:

  • Multiple sclerosis (MS) exhibited a significantly higher lesional g-ratio and lower myelin volume fraction (MVF) compared to MOGAD and NMOSD, indicating greater demyelination.
  • Increased deep-NAWM orientation dispersion index (ODI) was observed in MS patients compared to controls.
  • Within the MS cohort, clinical measures correlated with g-ratio, MVF, and NDI in both whole-brain and deep NAWM.

Conclusions:

  • Advanced MRI biomarkers provide nuanced characterization of microstructural changes in pediatric demyelinating diseases.
  • Distinct imaging profiles support the use of these metrics for clinical management and therapeutic stratification.
  • Longitudinal studies are needed to validate their role in monitoring disease progression and treatment response.

Related Concept Videos